Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)

NCT03942120 · clinicaltrials.gov ↗

COMPLETED

Status

685

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Ustekinumab

Sponsor

Janssen Korea, Ltd., Korea